• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相关性颌骨坏死继发于种植体周围炎:病例报告及文献复习。

Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.

机构信息

Department of Comprehensive Dentistry and Clinical Education, Nihon University School of Dentistry, Tokyo, Japan.

Department of Clinical Medicine, Nihon University School of Dentistry, Tokyo, Japan.

出版信息

J Oral Implantol. 2021 Dec 1;47(6):502-510. doi: 10.1563/aaid-joi-D-19-00385.

DOI:10.1563/aaid-joi-D-19-00385
PMID:33270837
Abstract

The aim of this report was to document a rare case of medication-related osteonecrosis of the jaw (MRONJ) that developed around the already osseointegrated implants in the maxillary right molar region. A 73-year-old woman presented at our university dental hospital in May 2017 with a chief complaint of discomfort near a maxillary implant. Her first visit was in 2006, and the maintenance treatment began in 2007 after the periodontal treatment. During the implant maintenance period there were no complications; however, the patient began taking alendronate sodium hydrate (Fosamac tablets, 35 mg, once weekly), an oral bisphosphonate (BP) since 2013, for treatment of osteoporosis. Eight years after starting implant maintenance, in 2016, peri-implantitis occurred, for which mechanical cleaning and antimicrobial therapy were performed. Peri-implantitis symptoms disappeared, and the medical condition improved. Nonetheless, in 2017, MRONJ developed 4 years after she commenced taking the BP. The patient underwent implant removal and sequestrectomy. There was no postoperative recurrence. Since it was such a rare case, we performed a literature review but only discovered a few similar cases. Because various triggers may lead to the development of MRONJ, even if already osseointegrated implant, it is important to note that implants in patients taking BPs should be more carefully maintained.

摘要

本报告旨在记录一例罕见的药物相关性下颌骨坏死(MRONJ)病例,该病例发生在右上颌磨牙区已骨整合的种植体周围。一名 73 岁女性于 2017 年 5 月因上颌种植体附近不适到我院牙科就诊。她于 2006 年首次就诊,并于 2007 年牙周治疗后开始进行维持治疗。在种植体维持期间没有发生并发症;然而,自 2013 年以来,该患者开始服用阿伦膦酸钠水合物(福善美片,35mg,每周一次),一种口服双膦酸盐(BP),用于治疗骨质疏松症。在开始进行种植体维护 8 年后,即 2016 年,发生了种植体周围炎,进行了机械清洁和抗菌治疗。种植体周围炎症状消失,病情好转。尽管如此,在开始服用 BP 4 年后的 2017 年,MRONJ 还是发生了。患者接受了种植体取出和清创术。术后无复发。由于这是一个罕见的病例,我们进行了文献复习,但只发现了少数类似病例。由于各种诱因都可能导致 MRONJ 的发生,即使种植体已经骨整合,也应注意,服用 BP 的患者的种植体应更仔细地维护。

相似文献

1
Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.药物相关性颌骨坏死继发于种植体周围炎:病例报告及文献复习。
J Oral Implantol. 2021 Dec 1;47(6):502-510. doi: 10.1563/aaid-joi-D-19-00385.
2
Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?种植体周围药物相关性颌骨坏死的临床特征:与种植体周围炎有关联吗?
J Craniomaxillofac Surg. 2016 Dec;44(12):1945-1951. doi: 10.1016/j.jcms.2016.09.018. Epub 2016 Oct 6.
3
Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.种植体周围炎样药物相关性颌骨坏死:临床思考与共聚焦激光扫描显微镜下的组织学评估。
Oral Dis. 2022 Sep;28(6):1603-1609. doi: 10.1111/odi.13873. Epub 2021 May 4.
4
Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?牙种植体周围药物相关性颌骨坏死:种植手术引发的还是种植体存在引发的骨坏死?
J Craniofac Surg. 2016 May;27(3):697-701. doi: 10.1097/SCS.0000000000002564.
5
Advanced Peri-Implantitis and Implant Removal as Risk Factors for Osteonecrosis of the Jaw in Patients on Oral Bisphosphonate Therapy.晚期种植体周围炎及种植体取出作为口服双膦酸盐治疗患者颌骨坏死的危险因素。
J Oral Implantol. 2021 Oct 1;47(5):420-426. doi: 10.1563/aaid-joi-D-20-00298.
6
Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.与口服双膦酸盐、牙周炎和牙种植体取出相关的戏剧性下颌骨坏死。
J Clin Periodontol. 2015 Feb;42(2):190-5. doi: 10.1111/jcpe.12322. Epub 2015 Feb 2.
7
Successful New Dental Implant Installation in a Healed Site of Medication-Related Osteonecrosis of the Jaw: A Case Report.在颌骨药物相关性骨坏死愈合部位成功植入新型牙种植体:一例报告
J Oral Implantol. 2023 Apr 1;49(2):117-123. doi: 10.1563/aaid-joi-D-20-00295.
8
Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review.每周一次使用特立帕肽治疗牙种植体周围药物相关性颌骨坏死:一例报告及文献综述
J Oral Implantol. 2019 Oct;45(5):403-407. doi: 10.1563/aaid-joi-D-19-00040. Epub 2019 Aug 20.
9
Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).牙种植体作为颌骨药物相关性骨坏死(MRONJ)患者的危险因素。
Br J Oral Maxillofac Surg. 2020 Sep;58(7):771-776. doi: 10.1016/j.bjoms.2020.03.022. Epub 2020 Jul 3.
10
Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.接受抗吸收药物治疗患者的牙种植体临床及影像学结果:连续病例系列研究
J Oral Implantol. 2023 Feb 1;49(1):39-45. doi: 10.1563/aaid-joi-D-21-00035.

引用本文的文献

1
An Evaluation of the Peri-Implant Tissue in Patients Starting Antiresorptive Agent Treatment After Implant Placement: A Nested Case-Control Study.种植体植入后开始抗吸收剂治疗患者的种植体周围组织评估:一项巢式病例对照研究。
Medicina (Kaunas). 2025 Jul 25;61(8):1348. doi: 10.3390/medicina61081348.
2
Peri-implant inflammation increases the risk of osteonecrosis in mice treated with bisphosphonate.种植体周围炎症增加了用双膦酸盐治疗的小鼠发生骨坏死的风险。
J Periodontol. 2025 Apr 15. doi: 10.1002/JPER.24-0760.
3
A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study.
一项研究表明,在存在种植体功能的情况下,开始使用抗骨质疏松药物后,种植体周围组织临床参数的变化:一项前瞻性队列研究。
Int J Implant Dent. 2024 Nov 5;10(1):50. doi: 10.1186/s40729-024-00569-4.
4
Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series.药物相关性颌骨坏死:病例报告与病例系列的系统评价
Diseases. 2024 Sep 9;12(9):205. doi: 10.3390/diseases12090205.
5
Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review.抗吸收药物对骨结合牙种植体的影响:一项系统评价。
J Clin Med. 2024 Apr 3;13(7):2091. doi: 10.3390/jcm13072091.
6
Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate.种植体周炎增加了接受唑来膦酸盐治疗的大鼠中与骨整合种植体相关的药物相关性颌骨坏死的风险。
Sci Rep. 2024 Jan 5;14(1):627. doi: 10.1038/s41598-023-49647-4.
7
Peri-implant osteonecrosis of the jaw in a patient prescribed selective estrogen receptor modulators.一名服用选择性雌激素受体调节剂的患者发生种植体周围颌骨骨坏死。
J Dent Sci. 2023 Oct;18(4):1939-1940. doi: 10.1016/j.jds.2023.06.015. Epub 2023 Jun 24.
8
Influence of antiresorptive/antiangiogenic therapy on the surgical treatment outcomes of experimentally induced peri-implantitis lesions.抗吸收/抗血管生成治疗对实验性种植体周围炎病变手术治疗效果的影响。
Clin Oral Investig. 2023 Nov;27(11):6657-6666. doi: 10.1007/s00784-023-05275-w. Epub 2023 Oct 2.
9
Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP).抗吸收治疗在患有牙周炎的骨代谢患者中的应用。意大利矫形外科和创伤学会(SIOT)与意大利牙周病学和种植学会(SIdP)的联合立场文件。
J Orthop Traumatol. 2023 Jul 15;24(1):36. doi: 10.1186/s10195-023-00713-7.
10
Influence of antiresorptive/antiangiogenic therapy on the extension of experimentally induced peri-implantitis lesions.抗吸收/抗血管生成治疗对实验性种植体周围炎病变延伸的影响。
Clin Oral Investig. 2023 Jun;27(6):3009-3019. doi: 10.1007/s00784-023-04904-8. Epub 2023 Feb 17.